Members |
acceptabilityId |
3q23 microdeletion syndrome |
Acceptable (foundation metadata concept) |
3q26 microduplication syndrome |
Preferred (foundation metadata concept) |
3q26 microduplication syndrome (disorder) |
Preferred (foundation metadata concept) |
3q26q27 microdeletion syndrome |
Preferred (foundation metadata concept) |
3q26q27 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
3q27.3 microdeletion syndrome |
Preferred (foundation metadata concept) |
3q27.3 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
3q29 microdeletion syndrome |
Preferred (foundation metadata concept) |
3q29 microdeletion syndrome (disorder) |
Preferred (foundation metadata concept) |
3q29 microduplication |
Preferred (foundation metadata concept) |
3rd |
Acceptable (foundation metadata concept) |
3rd HiB and DTP vaccine given |
Preferred (foundation metadata concept) |
3rd HiB and DTP vaccine given (situation) |
Preferred (foundation metadata concept) |
3rd Hib and DTP vaccine given |
Preferred (foundation metadata concept) |
3rd Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
3rd Japanese encephalitis vaccination |
Preferred (foundation metadata concept) |
3rd Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
3rd Japanese encephalitis vaccination (procedure) |
Preferred (foundation metadata concept) |
3rd floor |
Acceptable (foundation metadata concept) |
3rd hepatitis A junior vaccination |
Acceptable (foundation metadata concept) |
3rd left lumbar vein |
Acceptable (foundation metadata concept) |
3rd nerve palsy |
Acceptable (foundation metadata concept) |
3rd nerve palsy |
Acceptable (foundation metadata concept) |
3rd right lumbar vein |
Acceptable (foundation metadata concept) |
3rd specimen |
Acceptable (foundation metadata concept) |
3rd trimester |
Acceptable (foundation metadata concept) |
3x /day |
Acceptable (foundation metadata concept) |
4 |
Acceptable (foundation metadata concept) |
4 |
Preferred (foundation metadata concept) |
4 |
Preferred (foundation metadata concept) |
4 (qualifier value) |
Preferred (foundation metadata concept) |
4 Buck shot |
Preferred (foundation metadata concept) |
4 Buck shot, device |
Acceptable (foundation metadata concept) |
4 Buck shot, device (qualifier value) |
Preferred (foundation metadata concept) |
4 French gauge |
Preferred (foundation metadata concept) |
4 French gauge (qualifier value) |
Preferred (foundation metadata concept) |
4 MUGS |
Acceptable (foundation metadata concept) |
4 PD base out prism test |
Acceptable (foundation metadata concept) |
4 WAY FOGGER |
Preferred (foundation metadata concept) |
4 WAY FOGGER (product) |
Preferred (foundation metadata concept) |
4 diopter prism test |
Preferred (foundation metadata concept) |
4 diopter prism test (procedure) |
Preferred (foundation metadata concept) |
4 hours |
Preferred (foundation metadata concept) |
4 hours (qualifier value) |
Preferred (foundation metadata concept) |
4 hours post-dose |
Preferred (foundation metadata concept) |
4 hours post-dose (qualifier value) |
Preferred (foundation metadata concept) |
4 level of presenting part in relation to ischial spines |
Preferred (foundation metadata concept) |
4 level of presenting part in relation to ischial spines (finding) |
Preferred (foundation metadata concept) |
4 millimole potassium exchanges/day |
Preferred (foundation metadata concept) |
4 millimole potassium exchanges/day (qualifier value) |
Preferred (foundation metadata concept) |
4 millimole potassium exchanges/kg body weight |
Preferred (foundation metadata concept) |
4 millimole potassium exchanges/kg body weight (qualifier value) |
Preferred (foundation metadata concept) |
4 millimole potassium exchanges/meal |
Preferred (foundation metadata concept) |
4 millimole potassium exchanges/meal (qualifier value) |
Preferred (foundation metadata concept) |
4 o'clock position |
Preferred (foundation metadata concept) |
4 o'clock position (qualifier value) |
Preferred (foundation metadata concept) |
4 o'clock position on mammogram |
Preferred (foundation metadata concept) |
4 o'clock position on mammogram (finding) |
Preferred (foundation metadata concept) |
4 part fracture |
Preferred (foundation metadata concept) |
4 part fracture (morphologic abnormality) |
Preferred (foundation metadata concept) |
4 pin head fixation device |
Preferred (foundation metadata concept) |
4 pin head fixation device (physical object) |
Preferred (foundation metadata concept) |
4 point gait |
Preferred (foundation metadata concept) |
4 point gait (finding) |
Preferred (foundation metadata concept) |
4 serotype |
Preferred (foundation metadata concept) |
4 serotype (qualifier value) |
Preferred (foundation metadata concept) |
4 serotypes |
Acceptable (foundation metadata concept) |
4 times a week |
Acceptable (foundation metadata concept) |
4 to 6 times a day |
Acceptable (foundation metadata concept) |
4'-hydroxybupivacaine |
Preferred (foundation metadata concept) |
4'-hydroxybupivacaine (substance) |
Preferred (foundation metadata concept) |
4+ pitting edema |
Preferred (foundation metadata concept) |
4+ pitting edema (finding) |
Preferred (foundation metadata concept) |
4,4'-dihydroxybiphenyl |
Preferred (foundation metadata concept) |
4,4'-dihydroxybiphenyl (substance) |
Preferred (foundation metadata concept) |
4,4'-dihydroxybiphenyl only product |
Preferred (foundation metadata concept) |
4,4'-dihydroxybiphenyl-containing product |
Preferred (foundation metadata concept) |
4,4'-methylene-bis-(2-chloroaniline) |
Preferred (foundation metadata concept) |
4,4'-methylene-bis-(2-chloroaniline) (substance) |
Preferred (foundation metadata concept) |
4,4'-oxydi-2-butanol |
Preferred (foundation metadata concept) |
4,4'-oxydi-2-butanol (substance) |
Preferred (foundation metadata concept) |
4,5-Dihydroxyhexanolactone |
Preferred (foundation metadata concept) |
4,5-Dihydroxyhexanolactone (substance) |
Preferred (foundation metadata concept) |
4,5-dihydroxyhexanoate |
Preferred (foundation metadata concept) |
4,5-dihydroxyhexanoate (substance) |
Preferred (foundation metadata concept) |
4,5-dihydroxyhexanoic acid lactone |
Acceptable (foundation metadata concept) |
4,5-dihydroxyphthalate decarboxylase |
Preferred (foundation metadata concept) |
4,5-dihydroxyphthalate decarboxylase (substance) |
Preferred (foundation metadata concept) |
4,6-dinitro-o-cresol (DNOC) causing toxic effect |
Acceptable (foundation metadata concept) |
4,6-dinitro-o-cresol causing toxic effect |
Acceptable (foundation metadata concept) |
4,6-dinitro-o-cresol causing toxic effect (disorder) |
Preferred (foundation metadata concept) |
4,7,10,13,16,19-Docosahexaenoic acid |
Preferred (foundation metadata concept) |
4,7,10,13,16,19-Docosahexaenoic acid (substance) |
Preferred (foundation metadata concept) |
4-(2,4-dichlorophenoxy)butyric acid |
Acceptable (foundation metadata concept) |
4-(2-carboxyphenyl)-2-oxobut-3-enoate aldolase |
Preferred (foundation metadata concept) |
4-(2-carboxyphenyl)-2-oxobut-3-enoate aldolase (substance) |
Preferred (foundation metadata concept) |
4-(dimethylamino)phenylazoxybenzene reductase |
Preferred (foundation metadata concept) |
4-(dimethylamino)phenylazoxybenzene reductase (substance) |
Preferred (foundation metadata concept) |
4-(phenylazo)benzenamine |
Acceptable (foundation metadata concept) |
4-2,4-dichlorophenoxybutanoic acid |
Preferred (foundation metadata concept) |
4-2,4-dichlorophenoxybutanoic acid (substance) |
Preferred (foundation metadata concept) |